Url Pharmaincis A Specialty Pharmaceutical Company Based In Philadelphia With Over 60 Years Of Experienceinitially Focused On Generic Drug Research And Manufacturingthe Company Has Transitioned To A Proprietary Branded Business Modelit Develops Innovative Products That Are Protected By Intellectual Property Or Regulatory Exclusivityaddressing Unmet Medical Needs The Company Markets Several Branded Prescription Medicationsincluding Qualaquina An Antimalarial Drugcolcrysa A Treatment For Goutand Fibricora Which Was Launched In 2009Url Pharma Emphasizes Clinical Safety Enhancements Through Formulation Development And Studiesand It Has A Pipeline Of Mid To Late Stage Products Expected To Launch Within Five Yearsavailable For Out Licensing Partnershipsthe Company Operates With Full Integration Across Technology Developmentmanufacturingand Commercializationtargeting Healthcare Providers And Patients In Niche Therapeutic Markets
